期刊文献+

以甲氨蝶呤为核心的类风湿关节炎的联合药物治疗 被引量:6

下载PDF
导出
摘要 早期应用甲氨蝶呤(MTX)治疗RA,除了控制疾病炎症的活动性外,还可以延长RA患者的总体生存时间。研究发现:MTX不仅对炎症反应有抑制作用,还具有抗动脉粥样硬化作用。MTX能够促进动脉粥样硬化形成过程中动脉壁内泡沫细胞中胆固醇的流出。因此,MTX对类风湿关节炎(RA)患者生存时间的延长或许归功于其对心血管事件及关节外受累的有益作用。
作者 陈楠 王振刚
出处 《中国医刊》 CAS 2013年第7期5-7,共3页 Chinese Journal of Medicine
  • 相关文献

参考文献14

  • 1Reiss AB, Carsons SE, Anwar K, et al. Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages [ J ]. Arthritis Rheum ,2008,58:3675-3683.
  • 2Rath T, Rubbert A. Drug combinations with methotrexate to treat rheumatoid arthritis[J]. Clin Exp Rheumatol,2010 ,28 :52-57.
  • 3Rau R. Efficacy of methotrexate in comparison to biologics in rheu- matoid arthritis[J]. Clin Exp Rheumatol,2010 ,28 :58-64.
  • 4Keystone E, Heijde D, Mason D Jr,et al. Certolizumab pegol plus methotrexate is significandy more effective than placebo plus metho- trexate in active rheumatoid arthritis: findings of a fifty-two-week, Phase Ⅲ, muhicenter, randomized, double-blind, placebo-controlled, parallel-group study [ J ]. Arthritis Rheum, 2008, 58 : 3319-3329.
  • 5Edwards JC, Szczepanski L, Szechinski J, et al. Efficacy of B-cell= targeted therapy with rituximab in patients with rheumatoid arthritis [J]. N Engl J Med,2004,350:2572-2581.
  • 6Kremer JM, Genant HK, Moreland LW,et al. Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial[J]. Ann Intern Med,2006,144:865-876.
  • 7Papagoras C, Voulgari PV, Dmsos AA. Strategies after the failure of the flint anti-tumor necrosis factor alpha agent in rheumatoid arthritis [ J]. Autoimmun Rev,2010,9:574-582.
  • 8Visser K, Katchamart W, Loza E, et al. Multinational evidence- based recommendations for the use of methotrexate in rheumatic dis- orders with a focus on rheumatoid arthritis: integrating systematic lit- erature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative[ J]. Ann Rheum Dis,2009,68: 1086-1093.
  • 9Yazici Y, Erkan D, Paget SA. Monitoring by rheumatologists for methotrexate, etanercept, infliximab, and anakinra-associated ad- verse events[J]. Arthritis Rheum,2003,48:2769-2772.
  • 10Abasolo L, Jadez E, Descalzo MA,et al. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a south Eu- ropean population[J]. Semin Arthritis Rheum,2008,37:388-397.

同被引文献92

  • 1李军,张奉春.糖皮质激素在类风湿关节炎中的应用[J].中国医刊,2004,39(8):11-13. 被引量:3
  • 2李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1780
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5221
  • 4菲尔斯坦.凯利风湿病学[M].粟占国,译.8版.北京:北京大学医学出版社.2011:1089.
  • 5吴兆苏,姚崇华,赵冬,等.11 省市队列人群心血管病发病前瞻性研究Ⅱ.个体危险因素聚集与心血管病发病的关系[J].中华心血管病杂志,2001,29(4):246-250.
  • 6Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population-based study [ J ]. Arthritis Rheum, 2005,52 (3) :722-732.
  • 7van Halm VP, Peters M J, Voskuyl AE, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross- sectional study, the CARRE Investigation [ J ]. Ann Rheum Dis, 2009,68 ( 9 ) : 1395-1400.
  • 8Peters MJ, Symmons DP, McCarey D, et al. EULAR evidence- based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis[J]. Ann Rheum Dis, 2010,69(2) :325-331.
  • 9Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis [ J ]. N Engl J Med, 1953,249 (14) :553-556.
  • 10Chung CP, Giles JT, Petri M, et al. Prevalence of traditional modi- fiable cardiovascular risk factors in patients with rheumatoid arthri- tis: comparison with control subjects from the multi-ethnic study of atheroselerosis[J]. Semin Arthritis Rheum, 2012,41(4) :535-544.

引证文献6

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部